TY - JOUR
T1 - Identification of C-6 as a New Site for Linker Conjugation to the Taccalonolide Microtubule Stabilizers
AU - Du, Lin
AU - Risinger, April L.
AU - Yee, Samantha S.
AU - Ola, Antonius R.B.
AU - Zammiello, Cynthia L.
AU - Cichewicz, Robert H.
AU - Mooberry, Susan L.
N1 - Publisher Copyright:
© 2019 American Chemical Society and American Society of Pharmacognosy.
PY - 2019/3/22
Y1 - 2019/3/22
N2 - The taccalonolides are a class of microtubule stabilizers that circumvent clinically relevant forms of drug resistance due to their unique mechanism of microtubule stabilization imparted by the covalent binding of the C-22-C-23 epoxide moiety to tubulin. A taccalonolide (8) with a fluorescein group attached with a linker at C-6 was generated, and biochemical and cell-based assays showed that it bound directly to tubulin and stabilized microtubules. This pharmacological probe has allowed, for the first time, a direct visualization of a taccalonolide binding to microtubules, verifying their cellular binding site. This C-6-modified taccalonolide showed potency comparable to the untagged compound in biochemical experiments; however, its potency was lower in cellular assays, presumably due to decreased cellular permeability. These studies provide a valuable tool to facilitate the further understanding of taccalonolide pharmacology and demonstrate that C-6 is a promising site for a linker to be added to this novel class of microtubule stabilizers for targeted drug delivery.
AB - The taccalonolides are a class of microtubule stabilizers that circumvent clinically relevant forms of drug resistance due to their unique mechanism of microtubule stabilization imparted by the covalent binding of the C-22-C-23 epoxide moiety to tubulin. A taccalonolide (8) with a fluorescein group attached with a linker at C-6 was generated, and biochemical and cell-based assays showed that it bound directly to tubulin and stabilized microtubules. This pharmacological probe has allowed, for the first time, a direct visualization of a taccalonolide binding to microtubules, verifying their cellular binding site. This C-6-modified taccalonolide showed potency comparable to the untagged compound in biochemical experiments; however, its potency was lower in cellular assays, presumably due to decreased cellular permeability. These studies provide a valuable tool to facilitate the further understanding of taccalonolide pharmacology and demonstrate that C-6 is a promising site for a linker to be added to this novel class of microtubule stabilizers for targeted drug delivery.
UR - http://www.scopus.com/inward/record.url?scp=85063317421&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063317421&partnerID=8YFLogxK
U2 - 10.1021/acs.jnatprod.8b01036
DO - 10.1021/acs.jnatprod.8b01036
M3 - Article
C2 - 30799622
AN - SCOPUS:85063317421
SN - 0163-3864
VL - 82
SP - 583
EP - 588
JO - Journal of Natural Products
JF - Journal of Natural Products
IS - 3
ER -